Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Shares outstanding
-
22.5M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
161K
-
Shares change
-
+161K
-
Total reported value, excl. options
-
$62.8K
-
Value change
-
+$62.8K
-
Number of buys
-
10
-
Price
-
$0.40
Significant Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q3 2024
10 filings reported holding VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar as of Q3 2024.
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 161K shares
of 22.5M outstanding shares and own 0.72% of the company stock.
Largest 10 shareholders include Warberg Asset Management LLC (67K shares), ARMISTICE CAPITAL, LLC (36K shares), Virtu Financial LLC (30.4K shares), HRT FINANCIAL LP (19.9K shares), Tower Research Capital LLC (TRC) (4.81K shares), UBS Group AG (2.87K shares), HARBOUR INVESTMENTS, INC. (152 shares), Federation des caisses Desjardins du Quebec (20 shares), Aspire Private Capital, LLC (14 shares), and BANK OF AMERICA CORP /DE/ (7 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.